Carbon Introduces Three New 3D Printing Materials Through DENTCA and DREVE Partnerships Medical
Through two new partnerships with DENTCA and DREVE, Carbon is introducing three new dental 3D-printing-focused materials.
News and Insights of 3D Printing and Manufacturing
HomeMedical
Through two new partnerships with DENTCA and DREVE, Carbon is introducing three new dental 3D-printing-focused materials.
Fischler Dental AG, a leading Swiss dental laboratory, renewed its trust in Prodways Technologies with the purchase of its second MOVINGLight ProMaker L5000 D dental 3D printer to increase its dental model production capacity while maintaining the precision and quality that have made its reputation.
Precision ADM, announced an investment in three metal additive manufacturing machines made by EOS, the world’s leading technology supplier in the field of industrial 3D printing of metals and polymers. The acquisition increases their AM capacity and capability, making it the largest direct metal laser sintering (DMLS) AM manufacturer in Canada with ISO 13485:2016 Quality Management System certification.
Advancements in the medical field have shown that 3D printing can be proficiently applied to many added value clinical applications. These include planning of a complex reconstruction in neurosurgery or improving the accuracy of custom-made implants for orthopedic reconstructions. The use of 3D printed surgical guides can reduce the time of surgery and enhance outcome. BRECA Health Care, a start up based in Granada, Spain is pioneering the design and manufacturing of custom-made medical devices with many patients treated worldwide during the last 7 years.
Zurich-based technology competence center inspire AG and the Hamburg-based consulting company Ampower cooperate by offering joint workshops for Additive Manufacturing. The aim of the cooperation is to enable industrial customers to implement Additive Manufacturing. The workshop program developed by inspire supports the customer in three steps over a period of 8 months in knowledge building, the identification of potential components, component design and the development of an implementation strategy within the company.
Chicago based startup Dimension Inx is leveraging its founders’ unique experience to launch a set of materials for 3D printing – or bioprinting – just about anything. These materials, that range from metals and graphene to bone-like mixtures – go by the name of 3D Paints. The underlying concept is that mixing them together transforms the 3D printer – or bioprinter – into a 3D canvas.
I had the pleasure of meeting and introducing Mr. Conor as a panel speaker during the recent AM Strategies conference in Washington DC. By day he works as a software engineer at General Electric. By night, he builds 3D printed custom prosthetic hands for his Handsmith project. With a small facility of four desktop 3D printers, Lyman has just fit his first patient and moved into production.
3D LifePrints UK Ltd, one of the UK’s leading medical 3D printing companies, has closed a Series A investment round of £500,000 with Fenwall Investments Ltd. This investment follows on from previous Seed Funding investment in 2016 and will enable accelerated expansion for this award-winning innovative company.
In segments such as regenerative medicine, neuroscience and drug discovery, 3D printing finds practical uses from cartilage repair, hearing aids to printable pills. In the challenge of fabricating biocompatible 3D microdevices, Nanoscribe’s 3D microprinting represents a versatile approach with the interplay of a high-resolution 3D printer and proprietary photo resin materials. The following scientific work in cell regeneration and nerve interfacing highlights the practicality of 3D-printed micro-objects harmless to living systems.
Researchers at the University of Glasgow developed a new method for drug manufacturing which uses 3D printers to create pharmaceuticals on demand. The study on 3D printed drugs, published in a new paper published today in the journal Science, could lead to a ‘Spotify for chemistry’. This would mark a new approach to the manufacturing of pharmaceuticals using a digital code, one that many are looking at as a potential breakthrough.